Director/PDMR Shareholding

Chemring

03/08/2026 15:35

RNS Number : 0689P
  
Chemring Group PLC
  
03 August 2026
  
 


3 August 2026
 
Chemring Group PLC
 
PDMR share dealing
 
 
Chemring Group PLC ("Chemring" or "the Company") announces that Sarah Ellard, a director of the Company, has today sold 57,597 ordinary 1p shares in the capital of the Company. Following this transaction, Mrs Ellard retains an interest in 210,000 ordinary 1p shares in the capital of the Company.
 
 
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
 




1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)
 


Name
 
 


 
 Sarah Ellard




2
 


Reason for the notification
 




a)
 


Position/status
 
 


Director/PDMR




b)
 


Initial notification /Amendment
 
 


Initial




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 




a)
 


Name
 
 


Chemring Group PLC




b)
 


LEI
 
 


213800U9A54VQJ5P2J41




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 
 




a)
 


Description of the financial instrument, type of instrument
 
Identification code
 
 


Ordinary 1p shares
 
 
 
GB00B45C9X44




b)
 


Nature of the transaction
 
 


Sale of ordinary 1p shares




c)
 


Price(s) and volume(s)
 
 


 




Price(s)
 


Volume(s)




 
602.1834p
 
 


 
57,597
 




 
 




d)
 


Aggregated information
 
 
- Aggregated volume
 
 
- Price
 
 


 
 
 
57,597
 
 
£346,839.57
 




e)
 


Date of the transaction
 
 


3 August 2026




f)
 


Place of the transaction
 
 


London, UK




 
For further information:
 




Chemring Group PLC








Sarah Ellard


Group Legal Director


+44 (0)7710 553757









 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHFLFVSTLIVIIR